These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2835932)

  • 41. Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma.
    Diete S; Treuheit T; Dietzmann K; Schmidt U; Wallesch CW
    J Neurooncol; 2001 May; 53(1):47-9. PubMed ID: 11678430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival and prognostic factors of anaplastic gliomas.
    Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
    Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme.
    Shrieve DC; Alexander E; Wen PY; Fine HA; Kooy HM; Black PM; Loeffler JS
    Neurosurgery; 1995 Feb; 36(2):275-82; discussion 282-4. PubMed ID: 7731507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen.
    McGirt MJ; Villavicencio AT; Bulsara KR; Friedman AH
    Surg Neurol; 2003 Apr; 59(4):277-81; discussion 281-2. PubMed ID: 12748009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
    Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
    Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
    Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retreatment of intracranial gliomas.
    Landy HJ; Feun L; Schwade JG; Snodgrass S; Lu Y; Gutman F
    South Med J; 1994 Feb; 87(2):211-4. PubMed ID: 8115886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implantation metastasis along the stereotactic biopsy tract in anaplastic astrocytoma: a case report.
    Kim JE; Kim CY; Kim DG; Jung HW
    J Neurooncol; 2003 Feb; 61(3):215-8. PubMed ID: 12675314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of malignant gliomas with neutron radiation.
    Griem ML
    Neurol Clin; 1985 Nov; 3(4):895-900. PubMed ID: 3001494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term survival in treated anaplastic astrocytomas. A report of combined RTOG/ECOG studies.
    Fischbach AJ; Martz KL; Nelson JS; Griffin TW; Chang CH; Horton J; Nelson DF
    Am J Clin Oncol; 1991 Oct; 14(5):365-70. PubMed ID: 1659173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
    Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
    J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereotactic radiosurgery for glial neoplasms of childhood.
    Grabb PA; Lunsford LD; Albright AL; Kondziolka D; Flickinger JC
    Neurosurgery; 1996 Apr; 38(4):696-701; discussion 701-2. PubMed ID: 8692387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography.
    Vertosick FT; Selker RG; Arena VC
    Neurosurgery; 1991 Apr; 28(4):496-501. PubMed ID: 1851971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
    Kuriyama H; Lamborn KR; O'Fallon JR; Iturria N; Sebo T; Schaefer PL; Scheithauer BW; Buckner JC; Kuriyama N; Jenkins RB; Israel MA
    Neuro Oncol; 2002 Jul; 4(3):179-86. PubMed ID: 12084348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.
    Grasbon-Frodl EM; Kreth FW; Ruiter M; Schnell O; Bise K; Felsberg J; Reifenberger G; Tonn JC; Kretzschmar HA
    Int J Cancer; 2007 Dec; 121(11):2458-64. PubMed ID: 17691113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade.
    Buckner JC; O'Fallon JR; Dinapoli RP; Schomberg PJ; Farr G; Schaefer P; Giannini C; Scheithauer BW; Ballman KV
    J Neurooncol; 2007 Sep; 84(3):279-86. PubMed ID: 17431544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
    Reardon DA; Akabani G; Coleman RE; Friedman AH; Friedman HS; Herndon JE; Cokgor I; McLendon RE; Pegram CN; Provenzale JM; Quinn JA; Rich JN; Regalado LV; Sampson JH; Shafman TD; Wikstrand CJ; Wong TZ; Zhao XG; Zalutsky MR; Bigner DD
    J Clin Oncol; 2002 Mar; 20(5):1389-97. PubMed ID: 11870184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.